enGene Holdings Inc.enGene Holdings Inc.enGene Holdings Inc.

enGene Holdings Inc.

No trades
See on Supercharts
Market capitalization
‪627.30 M‬USD
−5.15USD
‪−99.92 M‬USD
‪7.63 M‬
Beta (1Y)
0.84

About enGene Holdings Inc.

CEO
Jason D. Hanson
Website
Headquarters
Saint-Laurent
Employees (FY)
33
Founded
2023
FIGI
BBG01J3GCZQ9
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.